GLP-1 also slows gastric emptying, contributing to a longer feeling of fullness after meals and slower digestion of food, which helps moderate blood sugar levels
As with many peptide-based compounds, reported side effects may include: Nausea or digestive discomfort Temporary appetite suppression beyond expectations Fatigue during early use phases These effects are often associated with metabolic adaptation
Semaglutide (Wegovy, Ozempic, and Rybelsus) Semaglutide is in a category of prescription drugs called glucagon-like peptide-1 agonists, or GLP-1s, and they have upended the way obesity is treated
Its barely enough energy to keep the lights on
Benzyl alcohol is the preservative
Is a Retatrutide 4mg dose considered a low, mid, or higher research level